Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study

BACKGROUND: Central nervous system (CNS) brain metastasis of advanced non-small cell lung cancer (NSCLC) patients confers a worse quality of life and prognosis. The efficacy comparison of two first-generation epidermal growth factor receptor (EGFR) inhibitors erlotinib or gefitinib as first-line tre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Li, Meng-Xia, He, Hao, Ruan, Zhi-Hua, Zhu, Yu-Xi, Li, Rong-Qing, He, Xiao, Lan, Bao-Hua, Zhang, Zhi-Min, Liu, Guo-Dong, Xiao, Hua-Liang, Wu, Yan, Zhu, Bo, Wang, Ge, Yang, Zhen-Zhou
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5379522/
https://ncbi.nlm.nih.gov/pubmed/28376735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3165-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados